WASHINGTON — AstraZeneca reported Monday that its COVID-19 vaccine provided strong protection among adults of all ages in a long-anticipated U.S. study, a finding that could help rebuild public confidence in the shot around the world and move it a step closer to clearance in the U.S.
AstraZeneca: US data shows vaccine effective for all adults
Sign up for the Herald's free e-newsletter